Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2
- PMID: 33529670
- PMCID: PMC7846881
- DOI: 10.1016/j.ijcard.2021.01.051
Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2
Conflict of interest statement
Declaration of Competing Interest None author reported any conflict of interest directly or indirectly connected with this manuscript.
Figures

Comment in
-
Making things right! Shouldn't we screen patients with thromboembolic events for SARS-CoV-2 infection, during the pandemia?Int J Cardiol. 2021 Sep 1;338:286-287. doi: 10.1016/j.ijcard.2021.03.058. Epub 2021 Mar 29. Int J Cardiol. 2021. PMID: 33794231 Free PMC article. No abstract available.
References
-
- Puerta-Alcalde P., García-Vidal C. Profile of patients with COVID-19 treated in Spanish emergency departments during the 2020 pandemic. Emergencias. 2020;32:225–226. - PubMed
-
- Jiménez Hernández S., Lozano Polo L., Suñen Cuquerella G., Peña Pardo B., Espinosa B., Cardozo C., et al. Clinical findings, risk factors, and final outcome in patients diagnosed with pulmonary thromboembolism and COVID-19 in hospital emergency departments. Emergencias. 2020;32:253–257. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous